| Code | 4051C | ||||||||||
| MA number | EU/1/08/472/040 | ||||||||||
| Product Form: | tbl flm 49 (42x15 mg + 7x20 mg) (blis.PP/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 30.09.2008 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Xarelto_karta_pre_pacienta_granulát.pdf
|
| Dokument: |
Xarelto_karta_pre_pacienta_tablety.pdf
|
| Dokument: |
Xarelto_prirucka_pre_predpisujuceho_lekara.pdf
|
| Safety feature | Yes |
| Data update: | 09.02.2021 |
